Myomo (MYO) Shares Outstanding (Diluted Average) (2021 - 2025)
Myomo posted quarterly Shares Outstanding (Diluted Average) of $42.2 million for Q3 2025, up 12.87% year-on-year from $37.4 million in Q3 2024, and up 1.56% on a QoQ basis from $41.5 million in Q2 2025.
Myomo (MYO) has 5 years of Shares Outstanding (Diluted Average) data on file, last reported at $42.2 million in Q3 2025.
- For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) rose 12.87% year-over-year to $42.2 million; the trailing twelve-month figure through Sep 2025 stood at $42.2 million (up 12.87% YoY), and the FY2024 full-year result was $37.8 million, up 28.0% from the prior year.
- Shares Outstanding (Diluted Average) for Q3 2025 stood at $42.2 million, up from $41.5 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $42.2 million in Q3 2025 and bottomed at $5.4 million in Q2 2021.
- The 5-year median for Shares Outstanding (Diluted Average) is $26.8 million (2023), against an average of $23.7 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) soared 318.34%; it then advanced 11.11% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $5.8 million in 2021, then climbed by 20.94% to $7.1 million in 2022, then soared by 318.34% to $29.5 million in 2023, then gained by 28.0% to $37.8 million in 2024, then grew by 11.68% to $42.2 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $42.2 million (Q3 2025), $41.5 million (Q2 2025), and $41.5 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 42.17 Mn |
| Jun 30, 2025 | 41.52 Mn |
| Mar 31, 2025 | 41.45 Mn |
| Dec 31, 2024 | 37.76 Mn |
| Sep 30, 2024 | 37.36 Mn |
| Jun 30, 2024 | 37.37 Mn |
| Mar 31, 2024 | 36.75 Mn |
| Dec 31, 2023 | 29.50 Mn |
| Sep 30, 2023 | 27.54 Mn |
| Jun 30, 2023 | 26.00 Mn |
| Mar 31, 2023 | 24.20 Mn |
| Dec 31, 2022 | 7.05 Mn |
| Sep 30, 2022 | 7.06 Mn |
| Jun 30, 2022 | 6.92 Mn |
| Mar 31, 2022 | 6.89 Mn |
| Dec 31, 2021 | 5.83 Mn |
| Sep 30, 2021 | 5.68 Mn |
| Jun 30, 2021 | 5.42 Mn |